Cell Division — Current Affairs 2026
Current Affairs Connections
Breakthrough in CRISPR-based Gene Therapy for Progeria Targets Cell Division Errors
October 2025 (Projected)Researchers at a leading genomics institute have announced promising preclinical results for a novel CRISPR-Cas9 gene therapy aimed at Hutchinson-Gilford Progeria Syndrome, a rare genetic disorder causing premature aging. The therapy specifically targets the LMNA gene mutation, which leads to the production of progerin, a toxic protein that severely disrupts normal nuclear structure and cell division. By correcting this mutation, the therapy seeks to restore healthy cell proliferation and reduce cellular senescence, thereby extending cellular lifespan and mitigating disease progression. This development highlights the potential of precision gene editing to address fundamental errors in cell division that underpin genetic diseases.
UPSC Angle: This development is relevant for UPSC under Science & Technology, specifically Biotechnology and Human Health. It showcases the application of advanced genetic engineering (CRISPR) to correct fundamental errors in cell division, linking to topics like gene therapy, rare diseases, and the ethical considerations of germline vs. somatic cell editing. Aspirants should understand the mechanism of CRISPR and its implications for treating disorders related to cell cycle dysregulation.
Indian Scientists Develop Novel Small Molecule Inhibitor for Glioblastoma Targeting Cancer Cell Cycle
March 2024A research team at the Indian Institute of Science (IISc) has identified and synthesized a new small molecule that selectively inhibits the division of glioblastoma multiforme (GBM) cells, one of the most aggressive brain cancers. The molecule targets specific cyclin-dependent kinases (CDKs) that are overactive in GBM, thereby arresting the cell cycle at the G2/M checkpoint and inducing apoptosis in cancer cells while sparing healthy brain cells. This indigenous research holds significant promise for developing more effective and less toxic therapeutic strategies against challenging cancers, reducing the burden of disease in India.
UPSC Angle: This news is crucial for UPSC, connecting to Medical Biotechnology, Human Health and Disease, and India's scientific advancements. It exemplifies how understanding cell cycle regulation (CDKs, checkpoints) can lead to targeted cancer therapies. Aspirants should note the importance of indigenous research, the concept of targeted therapy, and the challenges of treating aggressive cancers like GBM. It also touches upon the broader theme of pharmaceutical innovation and drug discovery in India.